You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • THU0282 Clinical efficacy to a second anti-tnf therapy is associated with the development of antibodies against the first anti-TNF therapy in patients with spondyloartrhitis

Citation Tools

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Posters
Spondyloarthritis – treatment
THU0282 Clinical efficacy to a second anti-tnf therapy is associated with the development of antibodies against the first anti-TNF therapy in patients with spondyloartrhitis

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
García Carazo S, Plasencia C, Pascual Salcedo D, et al
THU0282 Clinical efficacy to a second anti-tnf therapy is associated with the development of antibodies against the first anti-TNF therapy in patients with spondyloartrhitis
Annals of the Rheumatic Diseases 2013;71:250-251.